Article
Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice
1 Sept 2024
Abstract excerpt
Pancreatic neuroendocrine tumors (pNETs) are the second most prevalent neoplasms of the pancreas with variable prognosis and clinical course. Our knowledge of the genetic alterations in patients with pNETs has expanded in the past decade with the availability of whole-genome sequencing and germline testing. This review will focus on potential clinical applications of the genetic testing in patients with pNETs....
Topics
Join the communities discussing this publication.
